Загрузка...
Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial
BACKGROUND: MB66 film is a multipurpose prevention technology (MPT) product with monoclonal antibodies (mAbs) against HIV-1 (VRC01-N) and HSV-1 and 2 (HSV8-N). The mAbs were produced by transient expression in Nicotiana benthamiana (N). We conducted a Phase I clinical trial to assess the safety, pha...
Сохранить в:
| Опубликовано в: : | PLoS Med |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Public Library of Science
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7857576/ https://ncbi.nlm.nih.gov/pubmed/33534791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1003495 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|